Delivery Order SPE2DB20D2014-SPE2DB24FC20R
Award Date
6/11/24
Potential Completion Date
6/12/24
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $3,144.38 firm fixed-price delivery order contract to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, which has no set-aside designation, is for the supply of 4564313232 - Cyclosporine 0.05% eye emulsion with an ultimate completion date of April 18, 2024. Amerisourcebergen holds a larger $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,138.48 firm fixed-price contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialized ophthalmic medication, with a completion date of March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of Cyclosporine 0.05% eye emulsion products to the U.S. government. The Delivery Order, valued at $1,845.39, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on May 20, 2024, with an ultimate completion date of May 21, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order for $2,092.92 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Cyclosporine 0.05% eye emulsion. This award has a completion date of March 6, 2024 and is not set aside. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $1,954.08 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a performance period through May 1, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $8,960.66 delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a pharmaceutical product used to treat various eye conditions. The contract has an ultimate completion date of August 13, 2024 and utilizes a Firm Fixed Price pricing structure. Amerisourcebergen, a major pharmaceutical distributor in the United States,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,351.96, is for the delivery of 30 units of Cyclosporine 0.05% Eye Emulsion. The contract has a completion date of February 21, 2023 and is a Firm Fixed Price contract. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as...
This is a Delivery Order valued at $7,949.34 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a period of performance through June 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor to the U.S. federal government. The $6,318.69 firm-fixed-price contract is for the supply of Cyclosporine 0.05% Eye Emulsion, a prescription medication, with a period of performance through March 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,434.74 firm fixed-price contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty medication used to treat dry eye disease. The contract has an ultimate completion date of March 31, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...